The effect of beta-blocker on hamster model BIO 53.58 with dilated cardiomyopathy determined using 123I-MIBG myocardial scintigraphy
123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy is currently used to evaluate cardiac sympathetic nerve function, but MIBG also has the capacity to evaluate dilated cardiomyopathy (DCM) severity and therapeutic effectiveness. In this study, we administered beta-blockers to a DCM hamster...
Gespeichert in:
Veröffentlicht in: | Annals of nuclear medicine 2003-12, Vol.17 (8), p.677-683 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 683 |
---|---|
container_issue | 8 |
container_start_page | 677 |
container_title | Annals of nuclear medicine |
container_volume | 17 |
creator | Inoue, Aritomo Yamashina, Shohei Yamazaki, Junichi |
description | 123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy is currently used to evaluate cardiac sympathetic nerve function, but MIBG also has the capacity to evaluate dilated cardiomyopathy (DCM) severity and therapeutic effectiveness. In this study, we administered beta-blockers to a DCM hamster model and evaluated the effect of therapy using MIBG. We also pathologically compared the effects of myocardial fibrosis suppression.
BIO 53.58 hamsters were divided into the following five groups based on beta-blocker administration: vehicle (COT), 2 mg/kg/day carvedilol (CLT), 20 mg/kg/day (CHT) carvedilol, 4 mg/kg/day (MLT) metoprolol, 40 mg/kg/day (MHT) metoprolol. F1B hamsters were administered a vehicle (COF). Plasma catecholamine, noradrenaline (p-NADR), adrenaline (p-ADR), and dopamine (p-DOPA) were assayed, and MIBG was performed. The count ratio of the heart to the mediastinum (H/M) and left ventricle myocardial washout ratio (WR) were calculated. We then performed an autopsy and calculated the percent change in fibrotic area from myocardial sections.
H/M of the initial image in the COT group was significantly lower at 2.4 +/- 0.2 than the 2.9 +/- 0.7 in the COF group (p < 0.05). The CLT and CHT groups had higher H/M values compared to the COT group (3.1 +/- 0.6, 3.0 +/- 0.6 versus 2.4 +/- 0.2: p < 0.05). Significant correlations were evident between the H/M of the delayed image and p-NADR and p-DOPA (p < 0.05, p < 0.01, respectively) as well as between WR and p-NADR and p-DOPA (p < 0.05). Percent change in fibrotic area was significantly lower in the beta-blocker groups than in the COT group (p < 0.05). Significant negative correlations were seen between the H/M of the delayed image and the percent change in fibrosis area.
The delayed image H/M and WR acutely reflected cardiac disorder and sympathetic nerve function disorder in BIO 53.58 hamsters. In the carvedilol-administered groups, there was improvement compared to the initial H/M image, indicating the efficacy of the beta-blocker in DCM. |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_71540176</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71540176</sourcerecordid><originalsourceid>FETCH-LOGICAL-j780-73dd6dd033b7338522d86488ee062b5d6c341e3899be46fc9f781c14947c73573</originalsourceid><addsrcrecordid>eNo1kDFPwzAUhD2AaCn8BeSJLciO49gZaQUlUlGX7JFjvzQuSRxiRyg7P5wIynQn3XdPeneF1iSjSSSoFCt06_2ZkFhyGd-gFU0yQVNK1ui7aABDXYMO2NW4gqCiqnX6A0bsetyozofFds5Ai7f5EXP2xCX-sqHBxrYqgMFajca6bnaDCs2MDSyNzvZLMnnbnzCNWR6959s9XphfWLXYa9sHexrV0Mx36LpWrYf7i25Q8fpS7N6iw3Gf754P0VlIEglmTGoMYawSjEkex0amiZQAJI0rblLNEgpMZlkFSVrrrBaS6uXVRGjBuGAb9Ph3dhjd5wQ-lJ31GtpW9eAmXwrKE0JFuoAPF3CqOjDlMNpOjXP5Pxv7AckiZ3U</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71540176</pqid></control><display><type>article</type><title>The effect of beta-blocker on hamster model BIO 53.58 with dilated cardiomyopathy determined using 123I-MIBG myocardial scintigraphy</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><source>SpringerLink Journals - AutoHoldings</source><creator>Inoue, Aritomo ; Yamashina, Shohei ; Yamazaki, Junichi</creator><creatorcontrib>Inoue, Aritomo ; Yamashina, Shohei ; Yamazaki, Junichi</creatorcontrib><description><![CDATA[123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy is currently used to evaluate cardiac sympathetic nerve function, but MIBG also has the capacity to evaluate dilated cardiomyopathy (DCM) severity and therapeutic effectiveness. In this study, we administered beta-blockers to a DCM hamster model and evaluated the effect of therapy using MIBG. We also pathologically compared the effects of myocardial fibrosis suppression.
BIO 53.58 hamsters were divided into the following five groups based on beta-blocker administration: vehicle (COT), 2 mg/kg/day carvedilol (CLT), 20 mg/kg/day (CHT) carvedilol, 4 mg/kg/day (MLT) metoprolol, 40 mg/kg/day (MHT) metoprolol. F1B hamsters were administered a vehicle (COF). Plasma catecholamine, noradrenaline (p-NADR), adrenaline (p-ADR), and dopamine (p-DOPA) were assayed, and MIBG was performed. The count ratio of the heart to the mediastinum (H/M) and left ventricle myocardial washout ratio (WR) were calculated. We then performed an autopsy and calculated the percent change in fibrotic area from myocardial sections.
H/M of the initial image in the COT group was significantly lower at 2.4 +/- 0.2 than the 2.9 +/- 0.7 in the COF group (p < 0.05). The CLT and CHT groups had higher H/M values compared to the COT group (3.1 +/- 0.6, 3.0 +/- 0.6 versus 2.4 +/- 0.2: p < 0.05). Significant correlations were evident between the H/M of the delayed image and p-NADR and p-DOPA (p < 0.05, p < 0.01, respectively) as well as between WR and p-NADR and p-DOPA (p < 0.05). Percent change in fibrotic area was significantly lower in the beta-blocker groups than in the COT group (p < 0.05). Significant negative correlations were seen between the H/M of the delayed image and the percent change in fibrosis area.
The delayed image H/M and WR acutely reflected cardiac disorder and sympathetic nerve function disorder in BIO 53.58 hamsters. In the carvedilol-administered groups, there was improvement compared to the initial H/M image, indicating the efficacy of the beta-blocker in DCM.]]></description><identifier>ISSN: 0914-7187</identifier><identifier>PMID: 14971610</identifier><language>eng</language><publisher>Japan</publisher><subject>3-Iodobenzylguanidine ; Adrenergic beta-Antagonists - administration & dosage ; Animals ; Carbazoles - administration & dosage ; Cardiomyopathy, Dilated - diagnostic imaging ; Cardiomyopathy, Dilated - drug therapy ; Cardiomyopathy, Dilated - pathology ; Cricetinae ; Disease Models, Animal ; Dose-Response Relationship, Drug ; Metoprolol - administration & dosage ; Propanolamines - administration & dosage ; Radionuclide Imaging ; Radiopharmaceuticals ; Severity of Illness Index ; Treatment Outcome</subject><ispartof>Annals of nuclear medicine, 2003-12, Vol.17 (8), p.677-683</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14971610$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Inoue, Aritomo</creatorcontrib><creatorcontrib>Yamashina, Shohei</creatorcontrib><creatorcontrib>Yamazaki, Junichi</creatorcontrib><title>The effect of beta-blocker on hamster model BIO 53.58 with dilated cardiomyopathy determined using 123I-MIBG myocardial scintigraphy</title><title>Annals of nuclear medicine</title><addtitle>Ann Nucl Med</addtitle><description><![CDATA[123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy is currently used to evaluate cardiac sympathetic nerve function, but MIBG also has the capacity to evaluate dilated cardiomyopathy (DCM) severity and therapeutic effectiveness. In this study, we administered beta-blockers to a DCM hamster model and evaluated the effect of therapy using MIBG. We also pathologically compared the effects of myocardial fibrosis suppression.
BIO 53.58 hamsters were divided into the following five groups based on beta-blocker administration: vehicle (COT), 2 mg/kg/day carvedilol (CLT), 20 mg/kg/day (CHT) carvedilol, 4 mg/kg/day (MLT) metoprolol, 40 mg/kg/day (MHT) metoprolol. F1B hamsters were administered a vehicle (COF). Plasma catecholamine, noradrenaline (p-NADR), adrenaline (p-ADR), and dopamine (p-DOPA) were assayed, and MIBG was performed. The count ratio of the heart to the mediastinum (H/M) and left ventricle myocardial washout ratio (WR) were calculated. We then performed an autopsy and calculated the percent change in fibrotic area from myocardial sections.
H/M of the initial image in the COT group was significantly lower at 2.4 +/- 0.2 than the 2.9 +/- 0.7 in the COF group (p < 0.05). The CLT and CHT groups had higher H/M values compared to the COT group (3.1 +/- 0.6, 3.0 +/- 0.6 versus 2.4 +/- 0.2: p < 0.05). Significant correlations were evident between the H/M of the delayed image and p-NADR and p-DOPA (p < 0.05, p < 0.01, respectively) as well as between WR and p-NADR and p-DOPA (p < 0.05). Percent change in fibrotic area was significantly lower in the beta-blocker groups than in the COT group (p < 0.05). Significant negative correlations were seen between the H/M of the delayed image and the percent change in fibrosis area.
The delayed image H/M and WR acutely reflected cardiac disorder and sympathetic nerve function disorder in BIO 53.58 hamsters. In the carvedilol-administered groups, there was improvement compared to the initial H/M image, indicating the efficacy of the beta-blocker in DCM.]]></description><subject>3-Iodobenzylguanidine</subject><subject>Adrenergic beta-Antagonists - administration & dosage</subject><subject>Animals</subject><subject>Carbazoles - administration & dosage</subject><subject>Cardiomyopathy, Dilated - diagnostic imaging</subject><subject>Cardiomyopathy, Dilated - drug therapy</subject><subject>Cardiomyopathy, Dilated - pathology</subject><subject>Cricetinae</subject><subject>Disease Models, Animal</subject><subject>Dose-Response Relationship, Drug</subject><subject>Metoprolol - administration & dosage</subject><subject>Propanolamines - administration & dosage</subject><subject>Radionuclide Imaging</subject><subject>Radiopharmaceuticals</subject><subject>Severity of Illness Index</subject><subject>Treatment Outcome</subject><issn>0914-7187</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kDFPwzAUhD2AaCn8BeSJLciO49gZaQUlUlGX7JFjvzQuSRxiRyg7P5wIynQn3XdPeneF1iSjSSSoFCt06_2ZkFhyGd-gFU0yQVNK1ui7aABDXYMO2NW4gqCiqnX6A0bsetyozofFds5Ai7f5EXP2xCX-sqHBxrYqgMFajca6bnaDCs2MDSyNzvZLMnnbnzCNWR6959s9XphfWLXYa9sHexrV0Mx36LpWrYf7i25Q8fpS7N6iw3Gf754P0VlIEglmTGoMYawSjEkex0amiZQAJI0rblLNEgpMZlkFSVrrrBaS6uXVRGjBuGAb9Ph3dhjd5wQ-lJ31GtpW9eAmXwrKE0JFuoAPF3CqOjDlMNpOjXP5Pxv7AckiZ3U</recordid><startdate>200312</startdate><enddate>200312</enddate><creator>Inoue, Aritomo</creator><creator>Yamashina, Shohei</creator><creator>Yamazaki, Junichi</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200312</creationdate><title>The effect of beta-blocker on hamster model BIO 53.58 with dilated cardiomyopathy determined using 123I-MIBG myocardial scintigraphy</title><author>Inoue, Aritomo ; Yamashina, Shohei ; Yamazaki, Junichi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-j780-73dd6dd033b7338522d86488ee062b5d6c341e3899be46fc9f781c14947c73573</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>3-Iodobenzylguanidine</topic><topic>Adrenergic beta-Antagonists - administration & dosage</topic><topic>Animals</topic><topic>Carbazoles - administration & dosage</topic><topic>Cardiomyopathy, Dilated - diagnostic imaging</topic><topic>Cardiomyopathy, Dilated - drug therapy</topic><topic>Cardiomyopathy, Dilated - pathology</topic><topic>Cricetinae</topic><topic>Disease Models, Animal</topic><topic>Dose-Response Relationship, Drug</topic><topic>Metoprolol - administration & dosage</topic><topic>Propanolamines - administration & dosage</topic><topic>Radionuclide Imaging</topic><topic>Radiopharmaceuticals</topic><topic>Severity of Illness Index</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Inoue, Aritomo</creatorcontrib><creatorcontrib>Yamashina, Shohei</creatorcontrib><creatorcontrib>Yamazaki, Junichi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of nuclear medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Inoue, Aritomo</au><au>Yamashina, Shohei</au><au>Yamazaki, Junichi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The effect of beta-blocker on hamster model BIO 53.58 with dilated cardiomyopathy determined using 123I-MIBG myocardial scintigraphy</atitle><jtitle>Annals of nuclear medicine</jtitle><addtitle>Ann Nucl Med</addtitle><date>2003-12</date><risdate>2003</risdate><volume>17</volume><issue>8</issue><spage>677</spage><epage>683</epage><pages>677-683</pages><issn>0914-7187</issn><abstract><![CDATA[123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy is currently used to evaluate cardiac sympathetic nerve function, but MIBG also has the capacity to evaluate dilated cardiomyopathy (DCM) severity and therapeutic effectiveness. In this study, we administered beta-blockers to a DCM hamster model and evaluated the effect of therapy using MIBG. We also pathologically compared the effects of myocardial fibrosis suppression.
BIO 53.58 hamsters were divided into the following five groups based on beta-blocker administration: vehicle (COT), 2 mg/kg/day carvedilol (CLT), 20 mg/kg/day (CHT) carvedilol, 4 mg/kg/day (MLT) metoprolol, 40 mg/kg/day (MHT) metoprolol. F1B hamsters were administered a vehicle (COF). Plasma catecholamine, noradrenaline (p-NADR), adrenaline (p-ADR), and dopamine (p-DOPA) were assayed, and MIBG was performed. The count ratio of the heart to the mediastinum (H/M) and left ventricle myocardial washout ratio (WR) were calculated. We then performed an autopsy and calculated the percent change in fibrotic area from myocardial sections.
H/M of the initial image in the COT group was significantly lower at 2.4 +/- 0.2 than the 2.9 +/- 0.7 in the COF group (p < 0.05). The CLT and CHT groups had higher H/M values compared to the COT group (3.1 +/- 0.6, 3.0 +/- 0.6 versus 2.4 +/- 0.2: p < 0.05). Significant correlations were evident between the H/M of the delayed image and p-NADR and p-DOPA (p < 0.05, p < 0.01, respectively) as well as between WR and p-NADR and p-DOPA (p < 0.05). Percent change in fibrotic area was significantly lower in the beta-blocker groups than in the COT group (p < 0.05). Significant negative correlations were seen between the H/M of the delayed image and the percent change in fibrosis area.
The delayed image H/M and WR acutely reflected cardiac disorder and sympathetic nerve function disorder in BIO 53.58 hamsters. In the carvedilol-administered groups, there was improvement compared to the initial H/M image, indicating the efficacy of the beta-blocker in DCM.]]></abstract><cop>Japan</cop><pmid>14971610</pmid><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0914-7187 |
ispartof | Annals of nuclear medicine, 2003-12, Vol.17 (8), p.677-683 |
issn | 0914-7187 |
language | eng |
recordid | cdi_proquest_miscellaneous_71540176 |
source | MEDLINE; Alma/SFX Local Collection; SpringerLink Journals - AutoHoldings |
subjects | 3-Iodobenzylguanidine Adrenergic beta-Antagonists - administration & dosage Animals Carbazoles - administration & dosage Cardiomyopathy, Dilated - diagnostic imaging Cardiomyopathy, Dilated - drug therapy Cardiomyopathy, Dilated - pathology Cricetinae Disease Models, Animal Dose-Response Relationship, Drug Metoprolol - administration & dosage Propanolamines - administration & dosage Radionuclide Imaging Radiopharmaceuticals Severity of Illness Index Treatment Outcome |
title | The effect of beta-blocker on hamster model BIO 53.58 with dilated cardiomyopathy determined using 123I-MIBG myocardial scintigraphy |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T21%3A09%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20effect%20of%20beta-blocker%20on%20hamster%20model%20BIO%2053.58%20with%20dilated%20cardiomyopathy%20determined%20using%20123I-MIBG%20myocardial%20scintigraphy&rft.jtitle=Annals%20of%20nuclear%20medicine&rft.au=Inoue,%20Aritomo&rft.date=2003-12&rft.volume=17&rft.issue=8&rft.spage=677&rft.epage=683&rft.pages=677-683&rft.issn=0914-7187&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E71540176%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71540176&rft_id=info:pmid/14971610&rfr_iscdi=true |